Whittier Trust’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-14,651
Closed -$944K 1419
2018
Q3
$944K Buy
14,651
+62
+0.4% +$3.78K 0.03% 292
2018
Q2
$712K Buy
14,589
+651
+5% +$33.7K 0.02% 321
2018
Q1
$655K Buy
13,938
+122
+0.9% +$5.87K 0.02% 337
2017
Q4
$688K Buy
13,816
+262
+2% +$13K 0.02% 323
2017
Q3
$785K Buy
13,554
+193
+1% +$11.5K 0.03% 307
2017
Q2
$897K Buy
13,361
+359
+3% +$22.7K 0.03% 281
2017
Q1
$852K Buy
13,002
+662
+5% +$40.9K 0.03% 283
2016
Q4
$701K Sell
12,340
-1
-0% -$58 0.03% 299
2016
Q3
$731K Buy
12,341
+25
+0.2% +$1.5K 0.03% 298
2016
Q2
$805K Buy
12,316
+149
+1% +$10.1K 0.04% 283
2016
Q1
$843K Hold
12,167
0.04% 273
2015
Q4
$893K Buy
12,167
+127
+1% +$9.03K 0.04% 278
2015
Q3
$854K Hold
12,040
0.04% 271
2015
Q2
$1.05M Hold
12,040
0.05% 270
2015
Q1
$884K Hold
12,040
0.04% 276
2014
Q4
$866K Hold
12,040
0.04% 275
2014
Q3
$833K Hold
12,040
0.04% 275
2014
Q2
$748K Hold
12,040
0.04% 288
2014
Q1
$657K Hold
12,040
0.03% 296
2013
Q4
$636K Buy
+12,040
New +$604K 0.03% 293

Other funds holding LPNT

Whittier Trust's LPNT Position: Q4 2018 in Review

Whittier Trust sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 14,651 shares — an estimated $944K sold.

Whittier Trust first reported a position in LPNT in Q4 2013 and held it in 20 quarters. The position peaked at $1.05M in Q2 2015. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

  • Whittier Trust reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Whittier Trust sold 14,651 LifePoint Health, Inc. shares in Q4 2018, an estimated $944K.
  • Whittier Trust first reported a position in LifePoint Health, Inc. in Q4 2013 and held it in 20 quarters.
  • Whittier Trust's LifePoint Health, Inc. position peaked at $1.05M in Q2 2015.
  • 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on Whittier Trust's 13F filing for Q4 2018, filed 7 Feb 2019.